Statera Biopharma Statistics

Total Valuation

STAB has a market cap or net worth of $42,850. The enterprise value is $6.92 million.

Market Cap	42,850
Enterprise Value	6.92M

Important Dates

The last earnings date was Thursday, October 5, 2023, before market open.

Earnings Date	Oct 5, 2023
Ex-Dividend Date	n/a

Share Statistics

STAB has 71.42 million shares outstanding.

Shares Outstanding	71.42M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.00%
Float	48.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.01
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.88
EV / EBITDA	0.15
EV / EBIT	0.15
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.05

Current Ratio	0.05
Quick Ratio	0.04
Debt / Equity	n/a
Debt / EBITDA	0.16
Debt / FCF	n/a
Interest Coverage	4.16

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-748.49%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$80,166
Profits Per Employee	-$2.07M
Employee Count	46
Asset Turnover	0.24
Inventory Turnover	0.58

Taxes

In the past 12 months, STAB has paid $4.49 million in taxes.

Income Tax	4.49M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -96.69% in the last 52 weeks. The beta is 281.36, so STAB's price volatility has been higher than the market average.

Beta (1Y)	281.36
52-Week Price Change	-96.69%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	53.48
Average Volume (30 Days)	28,080

Short Selling Information

The latest short interest is 1.25 million, so 1.75% of the outstanding shares have been sold short.

Short Interest	1.25M
Short Previous Month	829,131
Short % of Shares Out	1.75%
Short % of Float	2.59%
Short Ratio (days to cover)	0.39

Income Statement

In the last 12 months, STAB had revenue of $3.69 million and -$95.43 million in losses. Loss per share was -$2.61.

Revenue	3.69M
Gross Profit	2.59M
Operating Income	-88.20M
Pretax Income	-91.86M
Net Income	-95.43M
EBITDA	47.35M
EBIT	46.80M
Loss Per Share	-$2.61

Full Income Statement

Balance Sheet

The company has $506,098 in cash and $7.41 million in debt, giving a net cash position of -$6.90 million or -$0.10 per share.

Cash & Cash Equivalents	506,098
Total Debt	7.41M
Net Cash	-6.90M
Net Cash Per Share	-$0.10
Equity / Book Value	-10.24M
Book Value Per Share	-0.14
Working Capital	-21.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.86 million and capital expenditures -$103,367, giving a free cash flow of -$12.96 million.

Operating Cash Flow	-12.86M
Capital Expenditures	-103,367
Free Cash Flow	-12.96M
FCF Per Share	-$0.26

Full Cash Flow Statement

Margins

Gross margin is 70.27%, with operating and profit margins of -2,391.65% and -2,587.73%.

Gross Margin	70.27%
Operating Margin	-2,391.65%
Pretax Margin	-2,490.95%
Profit Margin	-2,587.73%
EBITDA Margin	1,284.12%
EBIT Margin	1,269.03%
FCF Margin	-351.55%

Dividends & Yields

STAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-85.80%
Shareholder Yield	-85.80%
Earnings Yield	-445,397.96%
FCF Yield	-60,508.65%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 28, 2015. It was a reverse split with a ratio of 1:20.

Last Split Date	Jan 28, 2015
Split Type	Reverse
Split Ratio	1:20

Scores

STAB has an Altman Z-Score of -5.4 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.4
Piotroski F-Score	4